SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-19-017736
Filing Date
2019-09-11
Accepted
2019-09-11 16:16:28
Documents
1
Period of Report
2019-09-09

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1526
  Complete submission text file 0001213900-19-017736.txt   3119
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Issuer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 100 WELLESLEY WAY FREEHOLD NJ 07728
Business Address
Guarino Jonathan L. (Reporting) CIK: 0001787282 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-14778 | Film No.: 191088486